Related Experiment Videos

Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse

I Hatada1, T Mukai

  • 1National Cardiovascular Center Research Institute, Osaka, Japan.

Nature Genetics
|October 1, 1995
PubMed

Insights

The p57KIP2 gene, a cell proliferation regulator, is genomically imprinted in mice. Its paternal allele is silenced and methylated, suggesting a role in tumor suppression and Beckwith-Wiedemann syndrome.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • p57KIP2 is a cell cycle inhibitor and tumor suppressor candidate.
  • The human p57KIP2 gene is on chromosome 11p15.5, a region linked to cancers and Beckwith-Wiedemann syndrome.
  • Loss of maternal 11p15 alleles in childhood tumors suggests genomic imprinting's role.

Purpose of the Study:

  • To investigate genomic imprinting of the p57KIP2 gene in mice.
  • To understand the genesis of human cancers in the 11p15.5 region.

Main Methods:

  • Analysis of the mouse homologue of p57KIP2.
  • Investigated gene imprinting patterns, including allele-specific expression and methylation.

Main Results:

  • The mouse p57KIP2 gene is genomically imprinted.
  • The paternally inherited allele is transcriptionally repressed.
  • The repressed paternal allele is methylated.
  • The murine gene maps to chromosome 7, near other imprinted genes.

Conclusions:

  • Genomic imprinting of p57KIP2 is conserved in mice.
  • Imprinting of p57KIP2 may contribute to its tumor suppressor function.
  • Further research into imprinting in the 11p15.5 region is warranted for cancer studies.

Related Concept Videos